Quarterly 13F snapshot: US-listed longs only, no performance figures — 13F data cannot support them.
Reported portfolio value by quarter (53 quarters reported)
$951M in Q2 2013 → — now. Hover for any quarter.
As reported for the quarter ended June 30, 2026. Activity is the change in share count since the prior quarter's filing.
| Holding | % of portfolio | Activity | Shares | Value |
|---|---|---|---|---|
| N N/a | NaN% | New | 0 | — |
What changed each quarter, from the filings' own share counts. Largest moves first; most recent 8 quarters.
quarter ended June 30, 2026 · filed August 13, 2026
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| Aura Biosciences Inc | Exited | −6,922,870 | −$46.3M | — |
| N N/a | New | +0 | — | — |
quarter ended March 31, 2026 · filed May 14, 2026
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| Maze Therapeutics Inc | Exited | −480,000 | −$19.9M | — |
quarter ended December 31, 2025 · filed February 13, 2026
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| Maze Therapeutics Inc | Trimmed | −1,173,684 | −$48.6M | 34.5% |
| Zentalis Pharmaceuticals Inc | Exited | −13,959,973 | −$21.1M | — |
quarter ended September 30, 2025 · filed November 13, 2025
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| Globalfoundries Inc | Exited | −3,475,000 | −$133M | — |
| Maze Therapeutics Inc | Trimmed | −832,500 | −$21.6M | 40.2% |
quarter ended June 30, 2025 · filed August 14, 2025
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| Globalfoundries Inc | Trimmed | −3,489,952 | −$133M | 59.6% |
quarter ended March 31, 2025 · filed May 14, 2025
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| AE Altair Engr Inc | Exited | −12,430,000 | −$1.36B | — |
| Globalfoundries Inc | Trimmed | −7,300,000 | −$269M | 74.0% |
| Perimeter Solutions Inc | Exited | −6,554,000 | −$83.8M | — |
| Maze Therapeutics Inc | New | +2,486,184 | +$27.4M | 7.9% |
quarter ended December 31, 2024 · filed February 13, 2025
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| Globalfoundries Inc | Trimmed | −2,250,000 | −$96.5M | 28.5% |
| PS Perimeter Solutions Sa | Exited | −6,725,000 | −$90.5M | — |
| Perimeter Solutions Inc | New | +6,554,000 | +$83.8M | 3.9% |
| Adaptimmune Therapeutics PLC | Exited | −37,681,515 | −$35.8M | — |
| AB Adaptive Biotechnologies Cor | Exited | −650,000 | −$3.33M | — |
quarter ended September 30, 2024 · filed November 14, 2024
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| Nvidia Corporation | Exited | −26,585,120 | −$3.28B | — |
| Qualcomm Inc | Exited | −10,000,000 | −$1.99B | — |
| Transdigm Group Inc | Exited | −1,094,900 | −$1.4B | — |
| Marvell Technology Inc | Exited | −15,055,500 | −$1.05B | — |
| AH Asml Holding N V | Exited | −927,200 | −$948M | — |
| Amazon Com Inc | Exited | −4,703,000 | −$909M | — |
| Synopsys Inc | Exited | −717,735 | −$427M | — |
| Workday Inc | Exited | −1,586,043 | −$355M | — |
| VS Veeva Sys Inc | Exited | −748,821 | −$137M | — |
| Ansys Inc | Exited | −323,778 | −$104M | — |
Showing the 10 largest of 20 changes.
Loading...
